HCAT Health Catalyst

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:

  • The Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat on Wednesday, September 4, 2024, at 1:30pm ET. The webcast link and related presentation materials will be available online at .
  • The Cantor Global Healthcare Conference, being held in New York, including a fireside chat on Tuesday, September 17, 2024, at 8:00am ET.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Health Catalyst Investor Relations Contact:

Jack Knight

Vice President, Investor Relations

+1 (855)-309-6800

Health Catalyst Media Contact:

Tarah Neujahr Bryan

Chief Marketing Officer



EN
27/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Health Catalyst

 PRESS RELEASE

Health Catalyst Reports Third Quarter 2024 Results

Health Catalyst Reports Third Quarter 2024 Results SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2024. “For the third quarter of 2024, I am pleased with our strong financial results, including total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, with these results exceeding the mid-point of our quarterly guidance on each metric. This financial performan...

 PRESS RELEASE

Health Catalyst to Announce Third Quarter 2024 Operating Results and H...

Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024 SALT LAKE CITY, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2024 operating results on Wednesday, November 6, 2024, after market close. In conjunction, the company will host a conference call to review the results at 4:30 pm ET on the same day. Conference Call Details The conference call can ...

 PRESS RELEASE

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Participate in Upcoming Investor Conferences SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Wells Fargo Healthcare Conference, being held in Boston, including a fi...

 PRESS RELEASE

Health Catalyst Reports Second Quarter 2024 Results

Health Catalyst Reports Second Quarter 2024 Results SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024. “For the second quarter of 2024, I am pleased by our strong financial results, including total revenue of $75.9 million and Adjusted EBITDA of $7.5 million, with these results exceeding the mid-point of our quarterly guidance on each metric. I am also pleased with our bo...

 PRESS RELEASE

Health Catalyst to Announce Second Quarter 2024 Operating Results and ...

Health Catalyst to Announce Second Quarter 2024 Operating Results and Host Conference Call on Wednesday, August 7, 2024 SALT LAKE CITY, July 24, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2024 operating results on Wednesday, August 7, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be access...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch